Anterogen.Co.,Ltd. (KOSDAQ:A065660) announced a private placement of 100,000 of registered convertible preferred stock at an issue price of KRW 60,000 for gross proceeds of KRW 6,000,000,000 on January 24, 2019. The securities are issued at a premium having a face value of KRW 500. The company will issue securities by a third party allotment method. The securities are convertible from February 1, 2020 to January 23, 2024. The payment date is February 1, 2019. All the securities issued in the transaction are subject to a lock up period of one year. The transaction will include participation from new investor DAYLI Empowering Biohealthcare Fund 2.